UQ-CHI: An Uncertainty Quantification-Based Contemporaneous Health Index for Degenerative Disease Monitoring

Developing knowledge-driven contemporaneous health index (CHI) that can precisely reflect the underlying patient across the course of the condition's progression holds a unique value, like facilitating a range of clinical decision-making opportunities. This is particularly important for monitoring degenerative condition such as Alzheimer's disease (AD), where the condition of the patient will decay over time. Detecting early symptoms and progression sign, and continuous severity evaluation, are all essential for disease management. While a few methods have been developed in the literature, uncertainty quantification of those health index models has been largely neglected. To ensure the continuity of the care, we should be more explicit about the level of confidence in model outputs. Ideally, decision-makers should be provided with recommendations that are robust in the face of substantial uncertainty about future outcomes. In this paper, we aim at filling this gap by developing an uncertainty quantification based contemporaneous longitudinal index, named UQ-CHI, with a particular focus on continuous patient monitoring of degenerative conditions. Our method is to combine convex optimization and Bayesian learning using the maximum entropy learning (MEL) framework, integrating uncertainty on labels as well. Our methodology also provides closed-form solutions in some important decision making tasks, e.g., such as predicting the label of a new sample. Numerical studies demonstrate the effectiveness of the propose UQ-CHI method in prediction accuracy, monitoring efficacy, and unique advantages if uncertainty quantification is enabled practice.

[1]  Hanieh Niroomand-Oscuii,et al.  Brain tumor growth simulation: model validation through uncertainty quantification , 2017, Int. J. Syst. Assur. Eng. Manag..

[2]  Shiliang Sun,et al.  Multi-view learning for visual violence recognition with maximum entropy discrimination and deep features , 2019, Inf. Fusion.

[3]  Sankaran Mahadevan,et al.  Uncertainty quantification in performance evaluation of manufacturing processes , 2014, 2014 IEEE International Conference on Big Data (Big Data).

[4]  L. Goddard Information Theory , 1962, Nature.

[5]  Joe Pitt-Francis,et al.  Bayesian Calibration, Validation and Uncertainty Quantification for Predictive Modelling of Tumour Growth: A Tutorial , 2017, Bulletin of Mathematical Biology.

[6]  Mert Sabuncu,et al.  Genetic variation and neuroimaging measures in Alzheimer disease. , 2010, Archives of neurology.

[7]  F. O. Hoffman,et al.  Propagation of uncertainty in risk assessments: the need to distinguish between uncertainty due to lack of knowledge and uncertainty due to variability. , 1994, Risk analysis : an official publication of the Society for Risk Analysis.

[8]  Zhe Wang,et al.  Semi-supervised soft margin consistency based multi-view maximum entropy discrimination , 2019 .

[9]  Shiliang Sun,et al.  Semi-supervised multi-view maximum entropy discrimination with expectation Laplacian regularization , 2019, Inf. Fusion.

[10]  Jianjun Shi,et al.  A Data-Level Fusion Model for Developing Composite Health Indices for Degradation Modeling and Prognostic Analysis , 2013, IEEE Transactions on Automation Science and Engineering.

[11]  R. Coleman,et al.  Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. , 2003, Radiology.

[12]  B. Spring,et al.  Healthy Apps: Mobile Devices for Continuous Monitoring and Intervention , 2013, IEEE Pulse.

[13]  Thomas Foltynie,et al.  Early nucleus basalis of Meynert degeneration predicts cognitive decline in Parkinson's disease. , 2018, Brain : a journal of neurology.

[14]  Daniel E. Rivera,et al.  Optimized Behavioral Interventions: What Does System Identification and Control Engineering Have to Offer? , 2012 .

[15]  Shuai Huang,et al.  DL-CHI: a dictionary learning-based contemporaneous health index for degenerative disease monitoring , 2018, EURASIP Journal on Advances in Signal Processing.

[16]  J. Haxby,et al.  NIH conference. Alzheimer disease: clinical and biological heterogeneity. , 1988, Annals of internal medicine.

[17]  Daoqiang Zhang,et al.  Multimodal classification of Alzheimer's disease and mild cognitive impairment , 2011, NeuroImage.

[18]  Shiliang Sun,et al.  Multi-View Maximum Entropy Discrimination , 2013, IJCAI.

[19]  Jiayu Zhou,et al.  Modeling disease progression via fused sparse group lasso , 2012, KDD.

[20]  Jeffrey L. Cummings,et al.  Cognitive and behavioral heterogeneity in Alzheimer’s disease: seeking the neurobiological basis , 2000, Neurobiology of Aging.

[21]  Tommi S. Jaakkola,et al.  Maximum Entropy Discrimination , 1999, NIPS.

[22]  Jean Marie Linhart,et al.  Estimating Parameters in Physical Models through Bayesian Inversion: A Complete Example , 2013, SIAM Rev..

[23]  Mark E. Schmidt,et al.  The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception , 2012, Alzheimer's & Dementia.

[24]  Yu Cheng,et al.  CHI: A contemporaneous health index for degenerative disease monitoring using longitudinal measurements , 2017, J. Biomed. Informatics.

[25]  David J. C. MacKay,et al.  Information Theory, Inference, and Learning Algorithms , 2004, IEEE Transactions on Information Theory.

[26]  D. Gallo,et al.  Uncertainty propagation of phase contrast-MRI derived inlet boundary conditions in computational hemodynamics models of thoracic aorta , 2017, Computer methods in biomechanics and biomedical engineering.

[27]  Viswanath Devanarayan,et al.  A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression , 2017, PloS one.

[28]  Guido De Roeck,et al.  Uncertainty quantification in operational modal analysis with stochastic subspace identification: Validation and applications , 2016 .

[29]  Robert P. Anderson,et al.  Maximum entropy modeling of species geographic distributions , 2006 .

[30]  David J. Field,et al.  Emergence of simple-cell receptive field properties by learning a sparse code for natural images , 1996, Nature.

[31]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[32]  Allen Y. Yang,et al.  Robust Face Recognition via Sparse Representation , 2009, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[33]  Naresh N. Nandola,et al.  A control systems engineering approach for adaptive behavioral interventions: illustration with a fibromyalgia intervention , 2014, Translational behavioral medicine.

[34]  Paul M. Thompson,et al.  Multi-source feature learning for joint analysis of incomplete multiple heterogeneous neuroimaging data , 2012, NeuroImage.

[35]  Chih-Chuan Chen,et al.  Credit rating with a monotonicity-constrained support vector machine model , 2014, Expert Syst. Appl..

[36]  Jiayu Zhou,et al.  Modeling disease progression via multi-task learning , 2013, NeuroImage.

[37]  Giovanni Biglino,et al.  Computational modelling for congenital heart disease: how far are we from clinical translation? , 2016, Heart.

[38]  M. Folstein Heterogeneity in Alzheimer's disease , 1989, Neurobiology of Aging.

[39]  B. Jenkins,et al.  Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[40]  G. Casella,et al.  The Bayesian Lasso , 2008 .

[41]  Paul Bannister,et al.  Uncertainty quantification of squeal instability via surrogate modelling , 2015 .

[42]  Richard Mayeux,et al.  A summary risk score for the prediction of Alzheimer disease in elderly persons. , 2010, Archives of neurology.